Anne Daguenel-Nguyen

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial

Michèlle Rosenzwajg, Roberta Lorenzon, P. Cacoub et al. · Annals of the Rheumatic Diseases · 2018 · 402 citations · Full text

Life Sciences, Immunology, Autoimmunity +11

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Jérôme Larghero, Anne Daguenel-Nguyen · The Lancet · 2020 · 360 citations · Full text

Life Sciences, Hematology, Immunology +14

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 296 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +14

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin, Nitin Jain, Marcela V. Maus et al. · The Lancet Haematology · 2022 · 136 citations · Full text

Life Sciences, Hematology, Immunology +14

Inhaled Sedation in Acute Respiratory Distress Syndrome

Matthieu Jabaudon, Jean‐Pierre Quenot, Julio Badié et al. · JAMA · 2025 · 46 citations · Full text

Medicine, Anesthesiology, Pharmacotherapy +17